AI IntelligenceMay 9, 2026Primary Market
Article
Nektar Therapeutics · Undisclosed · Unbekannt
Nektar Therapeutics filed an 8-K reporting entry into a material definitive agreement, potentially related to a licensing deal or capital raise.
Data Cube AI EditorialSource: SEC EDGAR
01
Source Brief
Nektar Therapeutics filed an 8-K reporting entry into a material definitive agreement, potentially related to a licensing deal or capital raise.
02